Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-011290

CHIEF EXECUTIVE OFFICER sold 2,804 shares at $48.74 ($136,656)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Matthew B. CHIEF EXECUTIVE OFFICER 2025-04-22 Sale 10b5-1 −2,804 $48.74 $136,656 273,234 D
Open-market sales · 2,804 sh · avg $48.74 · $136,656
Loading xslF345X05/form4-04242025_050401.xml…